Evidence map›Paper›PMID 25635513›Full record

ArticleAging2015

PCH-2 regulates Caenorhabditis elegans lifespan.

Hong Qian, Xiangru Xu, Laura E Niklason

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in pharmacology · 2022
    Article
  4. Antiaging, Stress Resistance, and Neuroprotective Efficacies ofOxidative medicine and cellular longevity · 2019
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hong QianDepartment of Anesthesiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Xiangru XuDepartment of Anesthesiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Laura E NiklasonDepartment of Anesthesiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Components or downstream targets of many signaling pathways such as Insulin/IGF-1 and TOR, as well as genes involved in cellular metabolism and bioenergetics can extend worm lifespan 20% or more. The C. elegans gene pch-2 and its homologs, including TRIP13 in humans, have been studied for their functions in cell mitosis and meiosis, but have never been implicated in lifespan regulation. Here we show that over-expression of TRIP13 in human fibroblasts confers resistance to environmental stressors such as UV radiation and oxidative stress. Furthermore, pch-2 overexpression in C. elegans extends worm lifespan, and enhances worm survival in response to various stressors. Conversely, reducing pch-2 expression with RNAi shortens worm lifespan. Additional genetic epistasis analysis indicates that the molecular mechanism of pch-2 in worm longevity is tied to functions of the sirtuin family, implying that pch-2 is another chromatin regulator for worm longevity. These findings suggest a novel function of the pch-2 gene involved in lifespan determination.

Indexed as

LongevityAdenosine TriphosphatasesAdolescentAdultAmino Acid SequenceAnimalsATPases Associated with Diverse Cellular ActivitiesCaenorhabditis elegansCaenorhabditis elegans ProteinsCarrier ProteinsCell Cycle ProteinsCells, CulturedChromatin Assembly and DisassemblyEpistasis, GeneticFibroblastsHumansAdenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesCaenorhabditis elegans ProteinsCarrier ProteinsCell Cycle ProteinsPCH-2 protein, C elegansTRIP13 protein, humanTrip13 protein, mouse

Identifiers

PMID25635513
PMCPMC4350321
OpenAlexW2186212084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.